PT - JOURNAL ARTICLE AU - Valter Augusto de Freitas Barbosa AU - Juliana Carneiro Gomes AU - Maíra Araújo de Santana AU - Jeniffer Emidio de Almeida Albuquerque AU - Rodrigo Gomes de Souza AU - Ricardo Emmanuel de Souza AU - Wellington Pinheiro dos Santos TI - Heg.IA: An intelligent system to support diagnosis of Covid-19 based on blood tests AID - 10.1101/2020.05.14.20102533 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.14.20102533 4099 - http://medrxiv.org/content/early/2020/05/18/2020.05.14.20102533.short 4100 - http://medrxiv.org/content/early/2020/05/18/2020.05.14.20102533.full AB - A new kind of coronavirus, the SARS-Cov2, started the biggest pandemic of the century. It has already killed more than 250,000 people. Because of this, it is necessary quick and precise diagnosis test. The current gold standard is the RT-PCR with DNA sequencing and identification, but its results takes too long to be available. Tests base on IgM/IgG antibodies have been used, but their sensitivity and specificity may be very low. Many studies have been demonstrating the Covid-19 impact in hematological parameters. This work proposes an intelligent system to support Covid-19 diagnosis based on blood testing. We tested several machine learning methods, and we achieved high classification performance: 95.159% ± 0.693 of overall accuracy, kappa index of 0.903 ± 0.014, sensitivity of 0.968 ± 0.007, precision of 0.938 ± 0.010 and specificity of 0.936 ± 0.011. These results were achieved using classical and low computational cost classifiers, with Bayes Network being the best of them. In addition, only 24 blood tests were needed. This points to the possibility of a new rapid test with low cost. The desktop version of the system is fully functional and available for free use.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially funded by the Federal University of Pernambuco, Brazil, and the Brazilian research agencies CNPq and CAPES.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code is freely available at GitHub repository "Heg.IA-Desktop" at "Biomedical-Computing-UFPE". https://github.com/Biomedical-Computing-UFPE/Heg.IA-Desktop